REFRACTORY HYPERLIPIDEMIA

Clinical trials for REFRACTORY HYPERLIPIDEMIA explained in plain language.

Never miss a new study

Get alerted when new REFRACTORY HYPERLIPIDEMIA trials appear

Sign up with your email to follow new studies for REFRACTORY HYPERLIPIDEMIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

One-Shot gene therapy aims to permanently lower heart disease risk

Disease control Recruiting now

This early-stage study is testing the safety of a new, one-time gene-editing treatment called VERVE-201. It is designed for people with dangerously high cholesterol and triglycerides that don't respond well to standard medications. The treatment works by editing a gene in the liv…

Matched conditions: REFRACTORY HYPERLIPIDEMIA

Phase: PHASE1 • Sponsor: Verve Therapeutics, Inc. • Aim: Disease control

Last updated Mar 23, 2026 15:17 UTC

REFRACTORY HYPERLIPIDEMIA

Get alerted when new REFRACTORY HYPERLIPIDEMIA trials appear

One-Shot gene therapy aims to permanently lower heart disease risk